Orion Properties faces elevated risk due to a going concern statement. Management has considerable experience in turnarounds and asset sales. Macro risks, especially political and economic uncertainty ...
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, announced that, as previously ...
10d
Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status
Multiple Sclerosis Drug Candidate Lucid-21-302 Phase 1 Trial with Toxicology Studies Complete, and unbuzzdâ„¢ Clinical Trial Published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results